Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders

Details for Australian Patent Application No. 2010224866 (hide)

Owner Genmedica Therapeutics SL

Inventors Mian, Alec; Marti Clauzel, Luc; Mayoux, Eric; Garcia Vicente, Silvia; Serrano Munoz, Marta; Zorzano Olarte, Antonio; Cesar Castro Palomino Laria, Julio

Agent Spruson & Ferguson

Pub. Number AU-A-2010224866

PCT Pub. Number WO2010/106082

Priority 61/177,958 13.05.09 US; 61/160,642 16.03.09 US; 61/227,620 22.07.09 US

Filing date 16 March 2010

Wipo publication date 23 September 2010

International Classifications

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/185 (2006.01) - Acids

A61K 31/192 (2006.01)

A61K 31/198 (2006.01)

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/106082 Priority application(s): WO2010/106082

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010224867-Combination therapies for treating metabolic disorders

2010224865-Piperidine derivatives as NK3 receptor antagonists